Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035
2.3 Market Size & Forecast, By Segmentation, 2022–2035
2.3.1 Market Size By Treatment Type
2.3.2 Market Size By Tumor Type
2.3.3 Market Size By Drug Class
2.3.4 Market Size By End User
2.3.5 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2025
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Patient Demographics
4.1.1 Patients by age group – % below 20 years, % between 40–60 years
4.1.2 Male vs female brain tumor cases – distribution %
4.2 Survival & Mortality Statistics
4.2.1 Glioblastoma vs meningioma – 5-year survival rate %
4.2.2 Mortality decline from early detection or advanced treatment – reduction %
4.3 Healthcare Access & Infrastructure
4.3.1 Hospitals equipped with advanced radiotherapy or proton beam facilities – availability %
4.3.2 Patients accessing treatment in urban vs rural areas – share %
4.4 Cost & Affordability Statistics
4.4.1 Patients delaying or skipping treatment due to cost – impact %
4.4.2 Therapies covered by insurance in developed vs emerging markets – coverage %
5. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Treatment Type, 2022 – 2035, Value (USD Billion)
5.1 Introduction
5.2 Surgery
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2022 – 2035
5.3 Radiation Therapy
5.4 Chemotherapy
5.5 Targeted Therapy
5.6 Immunotherapy
5.6 Others
6. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Tumor Type, 2022 – 2035, Value (USD Billion)
6.1 Introduction
6.2 Glioblastoma
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2022 – 2035
6.3 Meningioma
6.4 Pituitary Tumors
6.5 Astrocytoma
6.5 Others
7. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Drug Class, 2022 – 2035, Value (USD Billion)
7.1 Introduction
7.2 Alkylating Agents
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2022 – 2035
7.3 Antimetabolites
7.3 Hormonal Agents
7.3 Others
8. Brain Tumor Treatment Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion)
8.1 Introduction
8.2 Hospitals
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2022 – 2035
8.3 Specialty Clinics
8.4 Ambulatory Surgical Centers
8.5 Research & Academic Institutes
9. Brain Tumor Treatment Market Segmental Analysis & Forecast, By Distribution Channel, 2022 – 2035, Value (USD Billion)
9.1 Introduction
9.2 Hospital Pharmacies
9.2.1 Key Trends
9.2.2 Market Size & Forecast, 2022 – 2035
9.3 Retail Pharmacies
9.4 Online Pharmacies
10. Brain Tumor Treatment Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)
10.1 Introduction
10.2 North America
10.2.1 Key Trends
10.2.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022 – 2035
10.2.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022 – 2035
10.2.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022 – 2035
10.2.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022 – 2035
10.2.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035
10.2.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022 – 2035
10.2.7.1 USA
10.2.7.2 Canada
10.3 Europe
10.3.1 Key Trends
10.3.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022 – 2035
10.3.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022 – 2035
10.3.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022 – 2035
10.3.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022 – 2035
10.3.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035
10.3.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022 – 2035
10.3.7.1 Germany
10.3.7.2 UK
10.3.7.3 France
10.3.7.4 Italy
10.3.7.5 Spain
10.3.7.6 Russia
10.3.7.7 Poland
10.3.7.8 Rest of Europe
10.4 Asia-Pacific
10.4.1 Key Trends
10.4.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022 – 2035
10.4.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022 – 2035
10.4.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022 – 2035
10.4.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022 – 2035
10.4.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035
10.4.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022 – 2035
10.4.7.1 China
10.4.7.2 India
10.4.7.3 Japan
10.4.7.4 South Korea
10.4.7.5 Australia
10.4.7.6 ASEAN Countries
10.4.7.7 Rest of Asia-Pacific
10.5 Latin America
10.5.1 Key Trends
10.5.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022 – 2035
10.5.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022 – 2035
10.5.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022 – 2035
10.5.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022 – 2035
10.5.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035
10.5.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022 – 2035
10.5.7.1 Brazil
10.5.7.2 Argentina
10.5.7.3 Mexico
10.5.7.4 Colombia
10.5.7.5 Rest of Latin America
10.6 Middle East & Africa
10.6.1 Key Trends
10.6.2 Brain Tumor Treatment Market Size & Forecast, By Treatment Type, 2022 – 2035
10.6.3 Brain Tumor Treatment Market Size & Forecast, By Tumor Type, 2022 – 2035
10.6.4 Brain Tumor Treatment Market Size & Forecast, By Drug Class, 2022 – 2035
10.6.5 Brain Tumor Treatment Market Size & Forecast, By End User, 2022 – 2035
10.6.6 Brain Tumor Treatment Market Size & Forecast, By Distribution Channel, 2022 – 2035
10.6.7 Brain Tumor Treatment Market Size & Forecast, By Country, 2022 – 2035
10.6.7.1 UAE
10.6.7.2 Saudi Arabia
10.6.7.3 Qatar
10.6.7.4 Egypt
10.6.7.5 South Africa
10.6.7.6 Rest of Middle East & Africa
11. Competitive Landscape
11.1 Key Players' Positioning
11.2 Competitive Developments
11.2.1 Key Strategies Adopted (%), By Key Players, 2025
11.2.2 Year-Wise Strategies & Development, 2022 – 2035
11.2.3 Number Of Strategies Adopted By Key Players, 2025
11.3 Market Share Analysis, 2025
11.4 Treatment Type/Service & Tumor Type Benchmarking
11.4.1 Treatment Type/Service Specifications & Features By Key Players
11.4.2 Treatment Type/Service Heatmap By Key Players
11.4.3 Tumor Type Heatmap By Key Players
11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
11.6.1 Roche (F. Hoffmann-La Roche)
11.6.1.1 Company Overview & Snapshot
11.6.1.2 Treatment Type/Service Portfolio
11.6.1.3 Key Company Financials
11.6.1.4 SWOT Analysis
11.6.2 Novartis AG
11.6.3 Pfizer Inc.
11.6.4 Merck & Co., Inc.
11.6.5 Bristol-Myers Squibb
11.6.6 AstraZeneca
11.6.7 Bayer AG
11.6.8 Eisai Co., Ltd.
11.6.9 Amgen Inc.
11.6.10 Johnson & Johnson
11.6.11 AbbVie Inc.
11.6.12 Celldex Therapeutics
11.6.13 Novocure Ltd.
11.6.14 Antisense Pharma
11.6.15 Dr. Reddy’s Laboratories
11.6.16 Mankind Pharma
11.6.17 Daiichi Sankyo Co., Ltd.
11.6.18 BeOne Medicines (formerly BeiGene)
11.6.19 Teva Pharmaceutical Industries
11.6.20 DelMar Pharmaceuticals
12. Analyst Recommendations
12.1 SNS Insider Opportunity Map
12.2 Industry Low-Hanging Fruit Assessment
12.3 Market Entry & Growth Strategy
12.4 Analyst Viewpoint & Suggestions On Market Growth
13. Assumptions
14. Disclaimer
15. Appendix
15.1 List Of Tables
15.2 List Of Figures
Frequently Asked Questions
Ans: North America led the global market in 2025 with a 40.85% share, supported by strong FDA drug approvals, reimbursement systems, and advanced oncology infrastructure.
Ans: Fastest-growing region with 8.72% CAGR (2026–2035), led by China, Japan, and India.
Ans: Rising brain tumor cases, advanced imaging & surgery, targeted therapies, and strong R&D.
Ans: The global brain tumor treatment market was valued at USD 7.17 Billion in 2025 and is anticipated to reach USD 6.22 Billion by 2035.
Ans: The global brain tumor treatment market is projected to grow at a CAGR of 7.29% during the forecast period 2026–2035.